The Prelieve Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients (PRELIEVE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03030274 |
Recruitment Status :
Completed
First Posted : January 24, 2017
Last Update Posted : September 15, 2022
|
Sponsor:
Occlutech International AB
Information provided by (Responsible Party):
Occlutech International AB
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | May 1, 2021 |
Actual Study Completion Date : | March 2, 2022 |